Fred Telling is Director at CTI BIOPHARMA CORP (CTIC). They have made 20 open-market trades across 4 companies since 2010, most recently 2025-12-12.
CIK 0001382225
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
11 open-market purchases totalling $1.4M since 2011, against 9 sales. Across 7 scored buys the stock is up 35.9% at ninety days, and 34.1 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CTIC | 78,874 | $717K |
| OGEN | 34,538 | $15K |
| OGEN.BC | 1,355,354 | — |
| ORNI | 144,511 | — |
| Total | $732K |
Shares reported on the most recent Form 4, priced at the 2026-01-22 close. 2 holdings could not be priced and are excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 71% | 71% | 71% |
| Avg Move | +3.4% | +4.6% | +35.9% |
| Alpha | +1.7% | +6.0% | +34.1% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OGEN | SELL | 2025-12-12 | 2025-12-15 | $0.94 | $197 | +2.3% | +9.5% | -6.3% |
| OGEN | SELL | 2025-12-12 | 2026-01-22 | $0.94 | $198 | -9.3% | -24.7% | -23.5% |
| OGEN | SELL | 2024-12-06 | 2024-12-09 | $0.36 | $1K | +1.6% | -9.8% | -23.0% |
| OGEN | SELL | 2023-11-30 | 2023-12-01 | $3.57 | $12K | +45.7% | +98.8% | -58.1% |
| OGEN | BUY | 2022-06-17 | 2022-06-21 | $0.29 | $3K | +19.4% | +26.7% | +3.3% |
| OGEN | BUY | 2022-05-23 | 2022-05-25 | $0.29 | $24K | +1.4% | +8.1% | +23.3% |
| OGEN | BUY | 2022-05-20 | 2022-05-23 | $0.28 | $18K | +10.1% | +1.7% | +22.9% |
| OGEN | BUY | 2022-05-18 | 2022-05-20 | $0.28 | $20K | +17.8% | +6.9% | +35.8% |
| OGEN | BUY | 2022-03-30 | 2022-04-01 | $0.36 | $66K | -7.1% | -14.8% | -8.3% |
| OGEN | BUY | 2020-11-24 | 2020-11-25 | $0.37 | $37K | +10.1% | +4.9% | +175.5% |
| OGEN.BC | BUY | 2016-06-30 | 2016-07-01 | $0.52 | $1.0M | N/A | N/A | N/A |
| OGEN | BUY | 2014-11-14 | 2014-11-17 | $0.95 | $26K | -28.0% | -1.4% | -1.4% |
| CTIC | SELL | 2014-03-07 | 2014-03-07 | $3.75 | $271K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL | 2013-05-30 | 2013-05-31 | $1.24 | $80K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL | 2012-09-18 | 2012-09-20 | $2.86 | $54K | -2.5% | +1.7% | +1.7% |
| ORNI | BUY | 2012-07-31 | 2012-08-02 | $1.50 | $147K | N/A | N/A | N/A |
| ORNI | BUY | 2011-08-25 | 2011-08-29 | $2.39 | $15K | N/A | N/A | N/A |
| ORNI | BUY | 2011-08-22 | 2011-08-24 | $2.26 | $8K | N/A | N/A | N/A |
| CTIC | SELL | 2010-11-05 | 2010-11-08 | $0.39 | $84K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL | 2010-06-28 | 2010-07-01 | $0.42 | $44K | -2.5% | +1.7% | +1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.